Skip to content

Draft, not yet released. In stewardship review. Not indexed until the first approved release.

Metodología

How the edition was made: methods, the model card, the evidence cut and its age, the acceptance record and the glossary.

14 min read0 figures13 tables17 notesNR-XTECH-NEURO-GLOBAL-2026-BASELINE

Contenido
  1. ·Edition home
  2. ·Executive summary
  3. 1Neurotechnology is clinical hardware and a new class of personal data
  4. 2Key findings
  5. 3Systems and sectors at baseline
  6. 4Risks and capability
  7. 5Consumer neural data outside medical rules
  8. 6Readings from the other desks
  9. 7The 2027 agenda
  10. 8Systems in depth
  11. AMetodología
    1. A.1 Methods
    2. A.2 Model card, Neurotechnology System Model v0
    3. A.3 The baseline evidence cut
    4. A.4 Evidence age and coverage
    5. A.5 Evidence cards, two anchor sources
    6. A.6 Publication acceptance record
    7. A.7 Status words
    8. A.8 How the edition is made, released and corrected
    9. A.9 Glossary and abbreviations
    10. A.10 Technical annex
  12. BData appendix
  13. CReferences and record
  14. ·Complete edition, for print

A.1Métodos

The global baseline uses published values and four simple derivations. Each is shown in full so that any reader can reproduce it.

Table A.1Methods
No.DerivationCalculationResultado
(1)Ratio of median rate in2 to rate in178 ÷ 62about 1.3 times
(2)Gap between1 and natural conversation as stated in1160 ÷ 62about 2.6 times
(3)Months from preprint to journal version of the accuracy study3December 2023 to August 20248 months
(4)Share of the 2025 round in the reported pre-money valuation20650 ÷ 9,000about 7%
Table A.2Coupling strength scale (matrix and model card)
StrengthDefinición
STRONGa disruption in the source system has historically changed the target system’s service or output within one season, in more than one region
MODERATEan effect is documented but buffered or slower
WEAKan effect is plausible but not documented at global scale
Table A.3Status grammar
EtiquetaRegla
Declaradovalue as issued by its source, with year
Inferredreasoned from cited evidence; never a measurement
EstimadoNexus analytical value with stated method
Escenarioconditional on stated assumptions
Expert inputstructured editorial judgement awaiting evidence

A.2Model card, Neurotechnology System Model v0

Model ID
MDL-XT20-NEURO · v0.1
Finalidad
represent neurotechnology as clinical hardware and a source of neural data coupled to health, materials, finance, workforce and privacy
Familia
graph-based system of systems
Entradas
the cited sources of this edition; no proprietary data
Método
expert-specified coupling strengths (STRONG · MODERATE · WEAK) from assessments and analogue events
Validación
none yet, first validation against federation evidence in 2027
Incertidumbre
qualitative; strengths are hypotheses, not measurements
Dominio de validez
global scale; not for asset-, site- or country-level use
Reproducibilidad
strength table and sources published in this edition
20couplings

typed in v0

0strong

documented within one season

0moderate

documented, buffered

20weak

plausible, undocumented

A.3The baseline evidence cut

Every Nexus edition is published from a frozen evidence cut. The global baseline cut is documentary: it pins the exact edition of every source cited. Federation cuts begin with the first national Foundry cuts in 2027.

Cut ID
DC-XTECH-NEURO-GLOBAL-2026-B0
Tipo
baseline documentary cut
Resolution policy
pinned · as of 30 September 2026
Sources pinned
44 cited sources, each at the edition and access date in the references
Ejecuciones del modelo
none at baseline, analytical values are stated with their method
Digest
computed at freeze and recorded in the publication record
Supersedes
nothing, first cut of the series
Superseded by
the 2027 neurotechnology annual cut

Linaje

  1. 01

    source edition

  2. 02

    pinned citation

  3. 03

    finding

  4. 04

    page

  5. 05

    publication record

Table A.4From the baseline cut to the federation cut
ElementoBaseline 20262027 global annual
Fuentescited global publications, pinned by editionnational, regional and sector cuts through one graph
Analysisstated methods and editorial estimatestyped analysis specifications
ModelosNeurotechnology System Model v0 specificationmodel runs with receipts
Hallazgostwelve baseline findingsfindings re-bound to federation evidence
Revisiónfive passes scheduledfive passes on the exact digest

A.4Evidence age and coverage

A 2026 global edition rests on evidence observed in many different years. This page shows each time base, so that no single year label hides older evidence.

Table A.5Evidence age and coverage
IndicadorObservadoPublicadoCadenciaNext release
Speech decoding papers2023Aug 2023one-offfollow-up papers
Speech accuracy over time2023 preprint · 2024 journalDec 2023 · Aug 2024one-offmore participants
Brain-spine interface2023May 2023one-offlonger follow-up
Endovascular study2025Sep 2025one-offpeer-reviewed version
PRIME registry entry2026Jan 2026continuonext update
US neural data bill2025Sep 2025per sessioncommittee action
UNESCO Recommendation2025Nov 2025one-offnational uptake
Chinese implementation opinion2025Jul 2025periódico2027 milestones
Table A.6Coverage by system at baseline
SistemaCoberturaThinnest dimension
HardwarePARTIALfailure rates on a common basis
ClínicaPARTIALoutcomes beyond one year
Neural dataPARTIALconsumer practices
GobernanzaPARTIALtext of national laws
InversiónTHINmarket size and public funding
Energy and heatTHINpower and heat budgets
CompetenciasTHINworkforce numbers
MaterialsTHINdependence by platform
Table A.7Designed empty states: what is not bound, what would fill it and why
CampoSource that would fill itBlocker
Power and heat budgets of implanted interfacesdevice makers, regulators, peer-reviewed engineering papersno figure retrieved; the search for heating and power limits returned no quantitative source
Market size on a common definitionindustry statistics and audited company reports29two market-research pages give USD 1.27 and 2.57 billion for 2025; none is bound
Clinical workforce for implantation, programming and follow-upnational statistics, professional bodiesnot retrieved; capability rung stays LISTED
Long-term failure and explant rates across platformstrial reports, registries, manufacturersonly one-year results read78; no common reporting
Number of participants implanted per companycompany reports and registry updates132026company statement of 5 in June 2025; a company statement of 21 in January 2026 was reported by a news agency26
Peer-reviewed results for company-announced devicesjournals for each company claim1527company releases only; no paper located
Consumer neural data practices by companyregulators, advocacy and academic audits33report read; no figure used
Text of California, Montana and Connecticut neural data lawsstate legislature sites2541California chaptering record and sponsor release read; Montana and Connecticut read in a privacy forum tracker; bill texts not opened
Public funding totals for neurotechnology programmesministries, research councilsthe national research programme budget page returned an access error
Electrode materials and fabrication dependence by platformindustry and trade statisticsonly a 2018 materials roadmap abstract read23
Status of the MIND Act after referral to committeecongressional recordstatus read from bill text and a release only
Reimbursement and access to implants by countryhealth ministries, insurersnot reviewed
Wearable and non-invasive interface deployment datacompanies, regulatorsone peer-reviewed paper32; no deployment figure
Capability rungs beyond guidance and planningagencies, hospitals, laboratoriesnot reviewed

A.5Evidence cards, two anchor sources

Published in Nature 620 (2023) by a Stanford-led group. One-off study. Role: binds INF-001 and the speech tiles. Coverage: one participant with ALS and four intracortical arrays.

EVD-XT20-001

A high-performance speech neuroprosthesis1

Introduced in the US Senate in 2025 as S. 2925. One-off text. Role: binds GOV-009. Coverage: US federal study of neural data; status was committee referral.

EVD-XT20-002

MIND Act of 2025 bill text11

Table A.8Quality dimensions at baseline
DimensionEVD-XT20-001EVD-XT20-002
Completenessone participant; 50-word and 125,000-word vocabulariesfull bill text; later status not read
Timelinesspublished online 23 August 2023introduced 2025
Revisionsingle paper versionamendments possible in committee
Method transparencymethods and data in the papertext public
External validationpeer reviewlegislative process

Evidence cards to follow in 2027

  • Willett et al.1: replication in more participants
  • Chetty et al.8: peer-reviewed version
  • MIND Act11: committee action
  • Registry entry13: updated enrolment

A.6Publication acceptance record

Editorial self-check at evidence close. Every applicable item carries a disposition; the remaining items are review, approval and deposit.

Table A.9Publication acceptance record
GrupoÁreaElementosAprobadoN/APendiente
D1Identity and scope8800
D2Source and data12912
D3Analysis and models12381
D4Findings and claims9801
D5Figures, tables, maps10622
D6Editorial and citations10802
D7Review and approval130013
D8Artefact and design12705
D9Registry and release9009

Publication gate

Conditions met
14 of 23 at evidence close
Blocking problems
none recorded
Open conditions
reviews, approval of the exact digest, deposit, registry pointer

Not applicable at baseline

Ejecuciones del modelo
first runs in Q1 2027
Mapas
plates in Q2 2027
Waivers
ninguno

A.7Status words

Table A.10The status every value carries
EstadoQué significa
ObservadoMeasured directly and published by the source.
DeclaradoPublished statistics of an official or institutional source.
DeclaradoStated by the body concerned; not independently measured.
EstimadoA Nexus estimate from cited evidence, with its method in Annex A.
ModeladoProduced by a stated model from cited inputs.
InferredReasoned from cited evidence; not measured.
PronósticoA projection by the cited source.
SimulatedA simulation result under stated assumptions.
EscenarioA conditional statement under stated assumptions; never a prediction.
Expert inputExpert judgement, recorded with its basis.
CandidateProposed for a later edition; not yet evidence.
Evidence-quality levels (EQL 1 to 5) grade the source behind a value; they are not a score of the subject.

A.8How the edition is made, released and corrected

Every edition is built from a sealed evidence cut, reviewed under three keys, signed and deposited before any site shows it as published; corrections go to Nexus Standards as change proposals and feed the next cut.

PasoQué ocurreFuente
01 Evidence arrives from the pillarsFoundry seals observations and indicator series, Universe hands over after-action and scenario findings, and contributions are screened at every gateway, including this site’s.
02 The cut is sealedOn the cut date the evidence is pinned under one identifier, so anyone can rebuild the edition from exactly what it was built on.
03 The edition is assembledThe edition is drafted from its template and content pack. Agents may draft; they never publish and never decide.
04 The keys turnAt the publisher of record the truth key comes first: every value is checked against its source or stated method before the meaning and capital keys turn. No edition moves on until every key has been turned by a named steward.
05 The gate opensA named approver releases one exact digest of the edition; any change after this point is a new version, never a silent edit.
06 Signed and depositedThe PDF, the web edition and the data bundle are signed together with a manifest and an RO-Crate description, and deposited on Zenodo with a concept and a version DOI.
07 Published on its desk’s siteOnly then does the edition show as published on its desk’s Reports site, and the Collection lists it as a part.
08 Corrections go to StandardsMethod and correction findings go to Nexus Standards as change proposals; citations, corrections and new contributions feed the next evidence cut.

A teaching model of the process, not a forecast and not a record of any run; dates and counts on this page come from the programme record. Sources: Reports governance at GCRI Canada (2026); Zenodo, repository of record for Reports deposits (2026).

Lifecycle, one state at a time: Draft, Computed, Evidence bound, Reviewed, Approved for release, Published, Corrected, Superseded. This edition is a draft.

A.9Glossary and abbreviations

Table A.11Series terms
TérminoSignificado
Baseline Editionthe inaugural annual edition that fixes the reference state for the series
WEFH+Bwater, energy, food, health and biodiversity, the national nexus core
Acoplamientoa typed dependency through which one system transmits to another
Brecha de protecciónthe share of losses not covered by insurance
Capability ladderLISTED → EXISTS → ADEQUATE → TESTED → DEMONSTRATED
EQLevidence-quality level, 1–5
Evidence cuta frozen resolution of exact sources and versions
NNC · NLC · NWGNational Nexus Consortium · National Leadership Council · National Working Groups
Table A.12Abbreviations used in this edition
AbbreviationExpansion
ALSamyotrophic lateral sclerosis
BCIbrain-computer interface
DBSdeep brain stimulation
EFSearly feasibility study
FDAUS Food and Drug Administration
FTCUS Federal Trade Commission
IDEinvestigational device exemption
MINDManagement of Individuals Neural Data
MIITMinistry of Industry and Information Technology of China
PRIMEPrecise Robotically Implanted Brain-Computer Interface study
UNESCOUnited Nations Educational, Scientific and Cultural Organization
WERword error rate

A.10Technical annex

Table A.13Technical annex
ElementoAnnexContenidoEstado
A.1Indicator definitionsthe global indicator set, with units and sourcesIN THIS EDITION
A.2Coupling strengthsthe twenty-cell matrix and its rationaleIN THIS EDITION
A.3Scenario specificationSCN-XT20-NDT-01 assumptions and signpostsIN THIS EDITION
A.4Capability placementsrung evidence for fifteen functionsIN THIS EDITION
A.5Diagnóstico del modelofirst runs and validation2027
A.6Análisis de sensibilidadinfluence of coupling strengths2027
A.7Cluster notescards for the major clinical interface clusters2027
A.8Review statementspass-by-pass review recordAT RELEASE

A.1 · indicator definition: word error rate

Construct
share of decoded words that differ from the words the participant intended to say
Unidad
por ciento
Método
attempted speech decoded by a trained model from implanted electrode signals, scored against the intended sentences
Fuente
Nature 620 (2023)12
Incertidumbre
as reported by the authors; not restated here
Límites conocidos
one participant per study; sentences and vocabulary set by the researchers

Notes

Numbers are the edition’s reference numbers, so a note reads the same in every chapter. The full list, with every source and its licence, is in Annex C. Annex C, references

  1. 2Metzger, S.L. et al., A high-performance neuroprosthesis for speech decoding and avatar control, Nature 620(7976), 1037 to 1046, published online 23 August 2023 (reference record read: median 78 words per minute; median word error rate 25%). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
  2. 1Willett, F.R. et al., A high-performance speech neuroprosthesis, Nature 620(7976), 1031 to 1036, published online 23 August 2023 (reference record read: 62 words per minute; 23.8% word error rate on 125,000 words; 9.1% on 50 words). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
  3. 3Card, N.S. et al., An accurate and rapidly calibrating speech neuroprosthesis, medRxiv preprint, 26 December 2023 (preprint record read: 99.6% on 50 words on day 1; 90.2% on 125,000 words on day 2; 97.5% beyond eight months; 256 electrodes; the record notes the New England Journal of Medicine version 391(7), 609 to 618, August 2024). Cold Spring Harbor Laboratory, New York. Observation year 2023. Accessed 2026-11-03.back
  4. 20Zeff, M., Elon Musk Neuralink closes a USD 650 million Series E (trade report, 2 June 2025; page read; vendor statement as reported: five people implanted; valuation of about USD 9 billion pre-money from an earlier press report). TechCrunch, San Francisco. Observation year 2025. Accessed 2026-11-03.back
  5. 29Mordor Intelligence (ed.), Brain-computer Interface Market Size and Share Analysis (report page updated 3 August 2026; USD 1.27 billion in 2025) and TechSci Research (ed.), Brain Computer Interface Market (report page, January 2026; USD 2.57 billion in 2025). Market-research pages, weak evidence; figures differ about twofold and none is used. Observation year 2025. Accessed 2026-11-05.back
  6. 7Lorach, H. et al., Walking naturally after spinal cord injury using a brain-spine interface, Nature 618(7963), 126 to 133, published online 24 May 2023 (reference record read: fully implanted; stable for over one year; one man with chronic tetraplegia). Springer Nature, London. Observation year 2023. Accessed 2026-11-03.back
  7. 8Chetty, N. et al., Signal properties and stability of a chronically implanted endovascular brain computer interface, medRxiv preprint, 25 September 2025 (preprint record read: five participants; 16-channel array; one year; not peer reviewed). Cold Spring Harbor Laboratory, New York. Observation year 2025. Accessed 2026-11-03.back
  8. 13ClinicalTrials.gov (ed.), PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices, NCT06429735 (record read: recruiting; start 9 January 2024; estimated enrolment 15; updated January 2026; sponsor-supplied entry). National Library of Medicine, Bethesda. Observation year 2026. Accessed 2026-11-03.back
  9. 26Santhosh, C., Elon Musk’s Neuralink says it has 21 participants enrolled in trials (Reuters, 28 January 2026, read as published by The Star; company statement of 21 participants enrolled worldwide, up from 12 in September 2025). News agency report of a company statement, weak evidence. Reuters, London. Observation year 2026. Accessed 2026-11-05.back
  10. 15Precision Neuroscience (ed.), company release on FDA 510(k) clearance of the Layer 7 Cortical Interface, 17 April 2025 (release read; vendor announcement, weak evidence: up to 30 days of implantation; 37 patients tested). Precision Neuroscience, New York. Observation year 2025. Accessed 2026-11-03.back
  11. 27Paradromics (ed.), Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus Brain-Computer Interface (company release of November 2025, read as reposted by BioSpace; IDE approval for an early feasibility study that will initially enrol two participants at three sites). Company statement, weak evidence. Paradromics, Austin. Observation year 2025. Accessed 2026-11-05.back
  12. 33Genser, J., Damianos, S. and Yuste, R., Safeguarding Brain Data: Assessing the Privacy Practices of Consumer Neurotechnology Companies (report for the Neurorights Foundation, April 2024; policy documents of 30 companies reviewed; no figure used). Neurorights Foundation, New York. Observation year 2024. Accessed 2026-11-05.back
  13. 25California Legislature (ed.), SB 1223 (Becker), Consumer privacy: sensitive personal information: neural data, Chapter 887, Statutes of 2024, chaptered 28 September 2024 (bill record read on CalMatters Digital Democracy; sponsor release of 27 September 2024: signed by the Governor, in effect 1 January 2025; the legislature page returned an access error). California Legislature, Sacramento. Observation year 2024. Accessed 2026-11-05.back
  14. 41Spivack, J. and Victory, C., State Neural Data Laws, Summer 2025 (Future of Privacy Forum chart, August 2025; Montana SB 163 adds neurotechnology data to the Genetic Information Privacy Act, effective 1 October 2025; Connecticut SB 1295 adds neural data to sensitive data under its data privacy act, most sections effective 1 July 2026). Secondary compilation; the state texts were not opened. Future of Privacy Forum, Washington. Observation year 2025. Accessed 2026-11-05.back
  15. 23Wellman, S.M. et al., A materials roadmap to functional neural interface design, Advanced Functional Materials 28(12), 2018 (reference record read; no figures in the abstract). Wiley, Weinheim. Observation year 2018. Accessed 2026-11-03.back
  16. 32Kaifosh, P., Reardon, T.R. and CTRL-labs at Reality Labs, A generic non-invasive neuromotor interface for human-computer interaction, Nature 645, 702 to 711, 2025 (Crossref record). Springer Nature, London. Observation year 2025. Accessed 2026-11-05.back
  17. 11United States Senate (ed.), Management of Individuals Neural Data Act of 2025 (MIND Act), S. 2925, 119th Congress, introduced text (text read: FTC study and report within one year of enactment; USD 10 million authorised; referred to committee). US Government Publishing Office, Washington. Observation year 2025. Accessed 2026-11-03.back

Downloads

Draft, not yet releasedReview copies of a draft in stewardship review. The released edition carries its DOI and replaces them.

  • Imprimir

    • PDF, A4

      The designed print edition, A4: cover, imprint and licence, how to cite, contents with page numbers, every chapter, figure, table and annex.

      PDF113 pages1.1 MBTagged, with bookmarks

      SHA-256 1b276afce6bca24b54678af9a98bba706f7ae5b11f20c2e49c30c56bd83684a0

    • PDF, US Letter

      The designed print edition, US Letter: cover, imprint and licence, how to cite, contents with page numbers, every chapter, figure, table and annex.

      PDF121 pages1.1 MBTagged, with bookmarks

      SHA-256 d43ae78f5a47684feb2d0ecc78a28696fdf3670c30a7369d28936ab2abf77a4a

  • Web edition

  • Paquete de datos

    • Indicators, CSV

      16 indicators with unit, year, status and source

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE-indicators.csv1 KB

      SHA-256 5fcebba27a41f952eb1984a1849d9a21e636ecbbb858a7cfd12593273299e02e

    • Indicators, JSON

      The same indicators with the edition’s identity and licence

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE-indicators.json2 KB

      SHA-256 84763ac2fc518c6e22a607df96e5cf665b378b7e2d5dae3a93a829a6138395b1

    • Findings, CSV

      12 findings with status, evidence-quality level and references

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE-findings.csv3 KB

      SHA-256 99d3e17ea329a61d07269b9c4fb66f9314005dd8eda895cb760a597a576e78e1

  • Citation files

    • Citation, BibTeX

      For LaTeX and reference managers

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE.bib1 KB

      SHA-256 631475c69ecb50a19d76d32931ee2d52190921f1d60804bf5ca3dc98f8422667

    • Citation, RIS

      For Zotero, EndNote and Mendeley

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE.ris1 KB

      SHA-256 cf6afd1f58373a90a8aa13996d249bb4d58205060d117a68bd590c7011178224

    • Citation, CITATION.cff

      Citation File Format 1.2.0, for GitHub, Zenodo and software catalogues

      NR-XTECH-NEURO-GLOBAL-2026-BASELINE.cff1 KB

      SHA-256 fe34e2f10f3e0a3621cd4df996367019140db054e8d7d94f0890286aba3f630e

Check a file with its SHA-256: shasum -a 256 <file> (macOS, Linux) or Get-FileHash <file> (Windows). Text, tables and figures by Nexus: CC BY 4.0; each source keeps its own licence.

Cite this annex

Valadbaygi, S. (Ed.). (2026). Annex A: Methodology. In Exponential Technology Report 2026: Neurotechnology and Human–Machine Interfaces (Baseline Edition 2026, Report No. NR-XTECH-NEURO-GLOBAL-2026-BASELINE) [Draft under review]. The Global Centre for Risk and Innovation (GCRI).

Every citation form of the whole report, BibTeX and RIS included, is on the edition home. Cite this report

serie ReportsContribuir

Send evidence or a correction on Neurotechnology and Human–Machine Interfaces.

Reports is the Consortium’s quarterly publication, written by six desks. This page sits with the Global Centre for Risk and Innovation (GCRI) Systems Evidence desk. What you know about this subject can become evidence, a case or a correction in the next edition, credited to you and published under CC BY 4.0 where it is your own work. Sent to the wrong desk, it is forwarded, not refused.

Oficina de Evidencia de Sistemas del GCRITecnología exponencial

CC BY 4.0 Free to read. Text and figures: CC BY 4.0. Data: CC0 1.0. Authors keep copyright. Published by GCRI Canada.